Published in
Springer, Cancer Immunology, Immunotherapy, 8(70), p. 2291-2300, 2021
DOI: 10.1007/s00262-020-02839-7
Links
Tools
T-VEC for stage IIIB-IVM1a melanoma achieves high rates of complete and durable responses and is associated with tumor load: a clinical prediction model
Journal article published in 2021 by
Emma H. A. Stahlie 
,
Viola Franke ,
Charlotte L. Zuur ,
Willem M. C. Klop ,
Bernies van der Hiel ,
Bart A. Van de Wiel ,
Michel W. J. M. Wouters ,
Yvonne M. Schrage ,
Winan J. van Houdt ,
Alexander C. J. van Akkooi
,
Viola Franke ,
Charlotte L. Zuur ,
Willem M. C. Klop ,
Bernies van der Hiel ,
Bart A. Van de Wiel ,
Michel W. J. M. Wouters ,
Yvonne M. Schrage ,
Winan J. van Houdt ,
Alexander C. J. van Akkooi
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 